Dr Queiroz was born in Campina Grande (Paraíba, Brazil) in 1971. He studied pharmaceutical sciences at UFPB Federal University of Paraíba from 1989-1994. During this period he received the CNPq scholarship for the ‘scientific initiation program’.
Later on, he was awarded by the prestigious RHAE-CNPq (Human Resources for Strategic Areas) scholarship of the Brazilian government to carry out his Ph.D. in the group of Prof. André Cavé´s, University of Paris XI. The aim of his work was the phytochemical study of two Annonaceae plants used in the Brazilian traditional Medicine. In 1999, he integrated Prof. Kurt Hostettmann’s group at University of Lausanne for a post-doctoral training. One year later he was promoted as ‘first assistant’.
During this period his research was devoted to the development new strategies for the ‘on-line’ identification of bioactive NPs from higher plants based on hyphenated techniques (LC/NMR and LC/MS) and he was also actively involved in the structure elucidation of the isolated compounds from very diverse origin. In 2005 he received the Econatura prime by the Ecosol in association with the Societé Suisse de Phytotherapie Medicale for the important contribution in the research of medicinal plants. During the period between 2006-2011 he works as a scientific manager in the research and development department of the biggest pharmaceutical company in South America; Aché Laboratórios Farmacêuticos S.A. in São Paulo, Brazil.
He was in charge of managing projects for the development of innovative drugs derived from Brazilian biodiversity and lead R&D team. He was also in charge of the scientific networks in Brazil and abroad. The launch of the herbal drug Syntocalmy® in the Brazilian market in 2011 was one of his most important achievements during this period. In 2010, his bibliographic profile was published by George Washington University, Creative & Innovative Economy Center due to his contribution among the Brazilian industrial sector.
Since Mai 2011, he is at Geneva University as a Senior Scientist (MER). His research is based on the development of methodologies for isolation of natural products on preparative scale and also miniaturized technological approaches for rapid and efficient identification of new drug-leads from natural sources. He has published 3 books, 10 book chapters, 90 research papers in international journals, 12 patents and has presented more than 100 contributions in international congress and symposiums. He wrote two books and several chapters on medicinal plants research. He is referee for over 15 International journals in natural product research and analytical chemistry.
He is associate editor of the Journal of Brazilian Chemical Society, member of the editorial board of the review Phytochemistry (The International Journal of Plant Chemistry, Plant Biochemistry and Molecular Biology) and member of the board of directors of the Society for Medicinal Plant and Natural Product Research (GA).

Graziella Rigueira Molska possui graduação em Farmácia pela Universidade Braz Cubas (2002-2005) e Mestrado e Doutorado em Ciências pelo Departamento de Psicobiologia da Universidade Federal de São Paulo (2007-2013). Atuou como pesquisadora do grupo de Plantas Medicinais sendo membro do Centro Brasileiro de Informações sobre Drogas Psicotrópicas (CEBRID) e colaborando com os trabalhos do Professor Dr. Elisaldo Luiz de Araújo Carlini (2013-2015). Tem experiência na área de psicofarmacologia, com ênfase em plantas medicinais com atividade no sistema nervoso central, principalmente as antinociceptivas. Atualmente é Pós-Doutoranda na University of Toronto, na qual tem trabalhado com modelos animais de dor orofacial.

Professional Aims
My work is focused in the preclinical and clinical development of nanomedicines to overcome barriers for the effective delivery and targeting of poorly soluble drugs and biomacromolecules (peptides, proteins, antibodies). I currently lead a research team of 2 PhDs, 1 Msc and 6 undergraduates and work closely with industrial and clinical collaborators in UK and abroad.

José Carlos Bouso es Psicólogo Clínico y doctor en Farmacología. Ha realizado estudios sobre los efectos a largo plazo de sustancias como el cannabis, la cocaína y la ayahuasca, así como estudios de efectos agudos de diferentes drogas de origen natural y sintético. También ha realizado estudios sobre los usos terapéuticos de la MDMA (éxtasis). Actualmente es Director de Proyectos Científicos de la Fundación ICEERS donde realiza estudios científicos sobre efectos a largo plazo de la ayahuasca, beneficios médicos del cannabis y el potencial anti-adictivo de la ibogaína.

Pablo Meléndez, nació en Santiago de Chile en el año 1984. Estudió Construcción Civil en la Pontificia Universidad Católica de Chile, dedicándose a su profesión hasta el año 2011, cuando comienza a colaborar y a dedicarse por completo a los proyectos y desafíos de Fundación Daya, organización sin fines de lucro, dedicada a la investigación, promoción e implementación de terapias orientadas a aliviar el sufrimiento humano, específicamente terapias en base a los usos medicinales del cannabis. Desde un principio, se hizo cargo, entre otras cosas, de las actividades agrícolas de la Fundación, supervisando en el año 2014, el primer cultivo autorizado de cannabis medicinal en Chile con fines de investigación, implementado por Fundación Daya.
En el año 2015, dirige un nuevo proyecto: el cultivo con fines medicinales más grande de Latinoamérica realizado en un terreno adquirido por Fundación Daya en el sur de Chile. Junto al equipo de técnicos, profesionales y trabajadores agrícolas, logró una cosecha de 1.5 toneladas de flor seca, correspondientes a 6900 plantas cultivadas en 1 hectárea de superficie.
Desde el año 2016, se desempeña como Director de Operaciones de DayaCann Spa, empresa creada por Fundación Daya y Auscann de Australia con el propósito de llevar a cabo los proyectos de cultivo en Chile.
En la actualidad y luego de dirigir cuatro proyectos anuales de cultivo de cannabis con fines medicinales y de investigación en su país, ha alcanzado poco más de 10.000 plantas cultivadas y 2.000 kilos de flores secas cosechadas. Así es como Pablo se ha transformado en un referente en el mundo del Cannabis, especialista en selección varietal, diseño de cultivos y plantas de procesos, compartiendo sus conocimientos y experiencias mediante la realización de cursos y talleres de autocultivo y de fabricación de preparados medicinales a lo largo de todo Chile.